293 results
Aspirin vs Clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study
08 Nov 2022
The HOST-EXAM trial1 was a prospective, randomised, open-label trial investigating clopidogrel monotherapy versus aspirin therapy in patients undergoing PCI with DES who had completed 6-18 months of DAPT with no ischaemic or bleeding complications. At 24 months follow-up, clopidogrel monotherapy significantly reduced the risk of the...
Reviewer
A patient with ACS – how should I treat the left main?
31 Oct 2022
Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.
Optical coherence tomography fractional flow reserve and cardiovascular outcomes in patients with acute coronary syndrome
18 Oct 2022
Optical Coherence Tomography fractional flow reserve (OCT-FFR) has been shown to correlate well with wire-based FFR; however, clinical outcomes based on OCT-FFR are not well defined. In this retrospective study, the authors sought to investigate the relationship between OCT-FFR and long-term clinical outcomes in ACS.
Reviewer
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.
Author
Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
30 Aug 2022
The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...
Reviewer
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
25 Aug 2022
In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...
Reviewer
How should I treat a patient at high-bleeding risk requiring complex distal Left Main PCI for ACS ?
17 Jun 2021
Discover the replay of this webinar on high bleeding risk and complex PCI, with E. Barbato, B. Chevalier, A. Chieffo and T. Cuisset
How to use invasive coronary physiology in ACS patients?
23 Sep 2021
Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)
09 Aug 2022
The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.
Reviewer
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk
18 Jul 2022
In this paper, the authors investigated the comparative efficacy and safety of TRA versus TFA in ACS patients undergoing complex PCI in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial1.
Reviewer
Reviewer
Distal versus conventional radial access for coronary angiography and intervention (DISCO RADIAL)
13 Jun 2022
The DISCO RADIAL trial sought to assess the efficacy and safety of distal radial access (DRA) compared with conventional transradial access (TRA) with systematic implementation of best prevention methods for the reduction of radial artery occlusion (RAO).
Reviewer
Reviewer
Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE
08 Jun 2022
The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.
Reviewer
Acute coronary syndrome: are women really so different?
18 May 2022 – From EuroPCR 2022
Lynne Hinterbuchner shares with Elena Calvo the take-home messages from this session in which a female patient gave a touching testimony, highlighting the importance of taking the patient's history into account.
The yield of intra-coronary assessment in NSTEMI
20 May 2022 – From EuroPCR 2022
Learn more about the yield of intra-coronary assessment in NSTEMI. This is explored through four different cases including a case of very late chronic coronary artery dissection, retrograde epicardial CTO, the use of FRR and OCT in decsion making during PCI as well as evolving ACS.
Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.
